Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)
1 Months Ended 12 Months Ended
Sep. 22, 2014
Sep. 30, 2014
Dec. 31, 2015
Dec. 31, 2014
Summary Of Significant Accounting Policies [Line Items]        
Cash equivalents, maturity period     Ninety days or less  
Impairment losses on long-lived assets     $ 0  
Income tax examination, likelihood of settlement, description     The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement.  
Income tax examination, likelihood of settlement, percentage     50.00%  
Deferred tax assets     $ 0 $ 0
Deferred tax liabilities     0  
Revenue since inception     0  
Total Assets     67,974,000 $ 107,744,000
Number of common shares issued on conversion of redeemable convertible preferred stock 14,860,173 14,860,173    
Laboratories [Member] | Non-US [Member]        
Summary Of Significant Accounting Policies [Line Items]        
Total Assets     $ 175,000